IdeS: A Bacterial Proteolytic Enzyme with Therapeutic Potential Clearance of Pathogenic IgG
2008

IdeS: A Bacterial Enzyme That Cleans Up Harmful Antibodies

Sample size: 6 publication 10 minutes Evidence: high

Author Information

Author(s): Johansson Björn P., Shannon Oonagh, Björck Lars

Primary Institution: Lund University

Hypothesis

Can IdeS effectively cleave and remove pathogenic IgG antibodies from the bloodstream?

Conclusion

IdeS can rapidly and efficiently degrade IgG antibodies in human blood and cure mice from lethal IgG-induced thrombocytopenia.

Supporting Evidence

  • IdeS completely degraded IgG in human blood in vitro within 15 minutes.
  • No IgG was detected in rabbits' blood six hours after IdeS injection.
  • Mice treated with IdeS survived lethal doses of IgG antibodies.

Takeaway

IdeS is like a special cleaner that can remove bad antibodies from the blood, helping sick animals get better.

Methodology

The study involved in vitro experiments with human blood and in vivo experiments with rabbits and mice to test the efficacy of IdeS in cleaving IgG.

Potential Biases

Potential bias due to the involvement of the authors in patent applications related to IdeS.

Limitations

The study primarily involved animal models, and further research is needed to address regulatory issues before human application.

Participant Demographics

The study involved healthy human donors for blood samples and rabbits and mice for in vivo experiments.

Digital Object Identifier (DOI)

10.1371/journal.pone.0001692

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication